2013
DOI: 10.1155/2013/523484
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin Protects against 1-Methyl-4-phenylpyridinium Ion- and Lipopolysaccharide-Induced Cytotoxicities in the Mouse Mesencephalic Astrocyte via Inhibiting the Cytochrome P450 2E1

Abstract: Curcumin is extracted from the rhizomes of the ginger family plant Curcuma longa L., which has a good protection for liver, kidney, and immune system. However, there is little information about its contribution in protection of astrocytes recently. The present study was undertaken to elucidate the protective effect of curcumin, an herbal antioxidant, on 1-methyl-4-phenylpyridinium ion- (MPP+-) and lipopolysaccharide- (LPS-) induced cytotoxicities, as well as the underlying mechanisms by using primary mouse mes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
5
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 44 publications
(58 reference statements)
1
5
0
Order By: Relevance
“…Accordingly, any reagent which has the ability to either inhibit or downregulate CYP2E1 would be a strong candidate for the prevention and treatment of toxicity induced by ACR. 31,39 The present study showed that curcumin inhibited the ACRinduced CYP2E1 overexpression in the liver and kidney tissues, which was in line with previous observations that curcumin acted as a CYP2E1-positive inhibitor in the liver 20,40 and kidney. 41,42 In view of the essential role of CYP2E1 in the development of ACR hepatotoxicity and nephrotoxicity through the generation of free radicals and the reactive metabolites from metabolism of ACR, it could be speculated that curcumin might protect against ACR-induced hepatic and renal impairment through the downregulation of CYP2E1 expression.…”
supporting
confidence: 92%
“…Accordingly, any reagent which has the ability to either inhibit or downregulate CYP2E1 would be a strong candidate for the prevention and treatment of toxicity induced by ACR. 31,39 The present study showed that curcumin inhibited the ACRinduced CYP2E1 overexpression in the liver and kidney tissues, which was in line with previous observations that curcumin acted as a CYP2E1-positive inhibitor in the liver 20,40 and kidney. 41,42 In view of the essential role of CYP2E1 in the development of ACR hepatotoxicity and nephrotoxicity through the generation of free radicals and the reactive metabolites from metabolism of ACR, it could be speculated that curcumin might protect against ACR-induced hepatic and renal impairment through the downregulation of CYP2E1 expression.…”
supporting
confidence: 92%
“…Also, CYP2E1, which is the hepatic P450 enzyme that contributes to the metabolic conversion of AOM into a colonic carcinogen, 56 has been observed to be inhibited by CUR. 57,58 Studies by Oetari et al suggest that, even at a CUR concentration of 30 μM, the extent of enzyme inhibition is <10%; therefore, we suspect that the effect of CUR was negligible. 57 Nevertheless, we cannot rule out the possibility that CUR and/or SAL supplementation confounded our results by altering AOM metabolism.…”
Section: Discussionmentioning
confidence: 88%
“…Likewise, a pure curcumin molecule showed effect on cancer prevention by inhibiting the activation of carcinogens or aflatoxin-DNA adduct by modulating the CYP450 activity [ 45 ]. Also in mouse brain astrocytes, pure curcumin inhibits CYP450 2E1 upon oxidative stress as its antioxidant properties [ 46 ]. Different Curcuma species from the same family Zingiberaceae have been studied.…”
Section: Discussionmentioning
confidence: 99%